PURITY: >= 98% (HPLC)
FORM: Lyophilized powder
DESCRIPTION:
PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide and melanocortin receptor agonist derived from the α-melanocyte-stimulating hormone (α-MSH) pathway. It acts on melanocortin receptors, with activity at multiple receptor subtypes including MC1R, MC3R, MC4R, and MC5R, and has been extensively studied in research involving melanocortin receptor signaling and central nervous system pathways associated with sexual function.
Molecular Formula: C₅₀H₆₈N₁₄O₁₀
Molecular Weight: 1,025.16 g/mol
PT-141 is supplied as lyophilized powder and is suitable for in-vitro and preclinical laboratory research involving melanocortin receptor pharmacology, receptor signaling, neurobiology, and related physiological pathways. PT-141 was previously investigated under the research designation PT-141 and is now known as bremelanotide.
For laboratory research purposes only. Not intended for human consumption, clinical use, or therapeutic application.
PURITY: >= 98% (HPLC)
FORM: Lyophilized powder
DESCRIPTION:
PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide and melanocortin receptor agonist derived from the α-melanocyte-stimulating hormone (α-MSH) pathway. It acts on melanocortin receptors, with activity at multiple receptor subtypes including MC1R, MC3R, MC4R, and MC5R, and has been extensively studied in research involving melanocortin receptor signaling and central nervous system pathways associated with sexual function.
Molecular Formula: C₅₀H₆₈N₁₄O₁₀
Molecular Weight: 1,025.16 g/mol
PT-141 is supplied as lyophilized powder and is suitable for in-vitro and preclinical laboratory research involving melanocortin receptor pharmacology, receptor signaling, neurobiology, and related physiological pathways. PT-141 was previously investigated under the research designation PT-141 and is now known as bremelanotide.
For laboratory research purposes only. Not intended for human consumption, clinical use, or therapeutic application.